Increase of interleukin‐10‐producing B cells associated with long‐term remission after i.v. immunoglobulin treatment for pemphigus
Authors:
- 12 February 2016
- journal article
- research article
- Published by Wiley in The Journal of Dermatology
- Vol. 43 (7) , 815-818
Abstract
We present a refractory case of pemphigus vulgaris that achieved long‐term remission after i.v. immunoglobulin treatment (IVIG). We evaluated the fluctuation of circulating interleukin‐10‐producing B cells (B10 cells) during the course in our case and other three patients with pemphigus treated with IVIG without clinical remission. B10 cells were observed predominantly in CD1d–, CD5–, CD9– and CD27+ populations among CD19+ cells in healthy controls, as well as in patients with pemphigus. The frequency of B10 cells among CD19+ cells increased in our case, but not in the other three patients without clinical remission, which leads to speculation on the association between the increase of B10 cells and the achievement of long‐term remission after IVIG treatment.Keywords
Funding Information
- Ministry of Education, Science, Sports and Culture, Japan (21791072)
This publication has 10 references indexed in Scilit:
- A regulatory CD9+B-cell subset inhibits HDM-induced allergic airway inflammationAllergy, 2015
- Increased Interleukin 21 and Follicular Helper T-like Cells and Reduced Interleukin 10+ B cells in Patients with New-onset Systemic Lupus ErythematosusThe Journal of Rheumatology, 2014
- Impaired function of CD19+CD24hiCD38hiregulatory B cells in patients with pemphigusBritish Journal of Dermatology, 2014
- Regulatory B10 Cells Are Decreased in Patients With Rheumatoid Arthritis and Are Inversely Correlated With Disease ActivityArthritis & Rheumatology, 2014
- Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell ResponseScience Translational Medicine, 2013
- Adult Kawasaki disease: Evaluating the fluctuation of circulating lymphocytes associated with i.v. immunoglobulin treatmentThe Journal of Dermatology, 2012
- Characterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cellsBlood, 2011
- IL-10 is Predominantly Produced by CD19(low)CD5(+) Regulatory B Cell Subpopulation: Characterisation of CD19 (high) and CD19(low) Subpopulations of CD5(+) B cellsYonsei Medical Journal, 2011
- What’s new in i.v. immunoglobulin therapy and pemphigus: High‐dose i.v. immunoglobulin therapy and its mode of action for treatment of pemphigusThe Journal of Dermatology, 2010
- A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory ResponsesImmunity, 2008